“"I agree with Martin Shkreli that when he raised the price of his drug he was within his rights because he had to reward his shareholders,“ Mulye was quoted as saying.“
“I think it is a moral requirement to make money when you can,” Mulye told the Financial Times, “to sell the product for the highest price.”